Glenmark Pharmaceuticals to launch Eribulin Mesylate Injection, 1mg/2Ml (0.5 mg/mL) single-dose… EP News Bureau Sep 2, 2025 Glenmark Pharmaceuticals, a research‐led, global pharmaceutical company has announced the launch of Eribulin Mesylate Injection, 1…
